Skip to main content

Vascular Catheter-Related Bloodstream Infections

  • Chapter
Surgical Intensive Care Medicine

Abstract

Intravascular catheters are inserted in most patients admitted to hospitals. Each year more than 150 million intravenous catheters are placed in patients admitted to hospitals. Intensive care unit patients may have multiple different intravenous catheters placed to administer fluids, medications, hemodynamic monitoring, or hemodialysis. This chapter focuses on the changing epidemiology, pathogenesis, diagnosis, and management of vascular catheter-related infections. These infections may be caused by a wide spectrum of bacterial pathogens as well as emerging fungal pathogens. Catheter-related bloodstream infections are associated with high mortality, morbidity, and enormous healthcare costs for acute and chronic care. Guidelines for the Diagnosis and Management of Catheter-Related Infections from the Infectious Diseases Society of America, as well as Guidelines for the Prevention of Intravenous Catheter-Related Infections from the Centers for Disease Control and Prevention are emphasized.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52:162–93.

    Article  Google Scholar 

  3. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990–May 1999, issued June 1999. Am J Infect Control. 1999; 27: 520–32.

    Google Scholar 

  4. Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, et al. Nosocomial infection rates in adult and pediatric intensive care a units in the United States. National Nosocomial Infections Surveillance System. Am J Med. 1991;91:185S–91.

    Article  CAS  PubMed  Google Scholar 

  5. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132:391–402.

    Article  CAS  PubMed  Google Scholar 

  6. Wenzel RP, Edmond MB. Team-based prevention of catheter related-infections. N Engl J Med. 2006;355:2781–3.

    Article  CAS  PubMed  Google Scholar 

  7. Centers for Disease Control and Prevention (CDC). Monitoring hospital-acquired infections to promote patient safety – United States, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49:149–53.

    Google Scholar 

  8. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med. 1995;155:1177–84.

    Article  CAS  PubMed  Google Scholar 

  9. Kiehn TE, Armstrong D. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices. Eur J Clin Microbiol Infect Dis. 1990;9:869–72.

    Article  CAS  PubMed  Google Scholar 

  10. Mayhall CG. Diagnosis and management of infections of implantable devices used for prolonged venous access. Curr Clin Top Infect Dis. 1992;12:83–110.

    CAS  PubMed  Google Scholar 

  11. Pearson ML. Guideline for prevention of intravascular device related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1996;24:262–77.

    Article  CAS  PubMed  Google Scholar 

  12. Elishoov H, Or R, Strauss N, Engelhard D. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine. 1998;77:83–101.

    Article  CAS  PubMed  Google Scholar 

  13. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunneled central venous catheters. Cancer. 1995;75:1367–75.

    Article  CAS  PubMed  Google Scholar 

  14. Nouwen JL, Wielenga JJ, van Overhagen H, Laméris JS, Kluytmans JA, Behrendt MD, et al. Hickman catheter-related infections in neutropenic patients: insertion in the operating theater versus insertion in the radiology suite. J Clin Oncol. 1999;17:1304.

    CAS  PubMed  Google Scholar 

  15. Adler A, Yaniv I, Steinberg R, Solter E, Samra Z, Stein J, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect. 2006;62:358–65.

    Article  CAS  PubMed  Google Scholar 

  16. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA. 1994;27:1014–6.

    Article  Google Scholar 

  17. Timsit JF, Farkas JC, Boyer JM, Martin JB, Misset B, Renaud B, et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest. 1998;114:207–13.

    Article  CAS  PubMed  Google Scholar 

  18. Passerini L, Lam K, Costerton JW, King EG. Biofilms on indwelling vascular catheters. Crit Care Med. 1992;20:665–73.

    Article  CAS  PubMed  Google Scholar 

  19. Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005;437:7–11.

    Article  PubMed  Google Scholar 

  20. Bjarnsholt T, Jensen PO, Burmolle M, Hentzer M, Haagensen JA, Hougen HP, et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology. 2005;151:373–83.

    Article  CAS  PubMed  Google Scholar 

  21. Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, Bagge N, et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 2003;22:3803–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005;28:1062–8.

    CAS  PubMed  Google Scholar 

  23. Cooper GL, Hopkins CC. Rapid diagnosis of intravascular catheter-associated infection by direct Gram staining of catheter segments. N Engl J Med. 1985;312:1142–7.

    Article  CAS  PubMed  Google Scholar 

  24. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med. 1987;147:873–7.

    Article  CAS  PubMed  Google Scholar 

  25. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296:1305–9.

    Article  CAS  PubMed  Google Scholar 

  26. Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis. 1980;141:781–6.

    Article  CAS  PubMed  Google Scholar 

  27. Sherertz RJ, Raad II, Belani A, Koo LC, Rand KH, Pickett DL, et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol. 1990;28:76–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168:400–7.

    Article  CAS  PubMed  Google Scholar 

  29. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med. 1999;340:1–8.

    Article  CAS  PubMed  Google Scholar 

  30. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med. 1997;127:257–66.

    Article  CAS  PubMed  Google Scholar 

  31. DesJardin JA, Falagas ME, Ruthazer R, Griffith J, Wawrose D, Schenkein D, et al. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med. 1999;131:641–7.

    Article  CAS  PubMed  Google Scholar 

  32. Capdevila JA, Planes AM, Palomar M, Gasser I, Almirante B, Pahissa A, et al. Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis. 1992;11:403–7.

    Article  CAS  PubMed  Google Scholar 

  33. Fan ST, Teoh-Chan CH, Lau KF. Evaluation of central venous catheter sepsis by differential quantitative blood culture. Eur J Clin Microbiol Infect Dis. 1989;8:142–4.

    Article  CAS  PubMed  Google Scholar 

  34. Blot F, Schmidt E, Nitenberg G, Tancrède C, Leclercq B, Laplanche A, et al. Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol. 1998;36:105–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S, et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet. 1999;354:1071–7.

    Article  CAS  PubMed  Google Scholar 

  36. Loonen, AM, Wolff PF, Buggerman CA. Eur Rapid pathogen identification allows early, appropriate therapy that will improve outcomes by decreases mortality, length of hospital stay and healthcare costs. J Clin Microbiol Infect Dis. 2014; in press.

    Google Scholar 

  37. Morrison J, Szeitzig D, Riccardello N, Rubino J, Axelband J, Sodowich B, et al. Retrospective analysis of clinical data associated with patients enrolled in a molecular diagnostic feasibility study highlights the potential utility for rapid detection of bloodstream infection. Am J Emerg Med. 2014;32:511–6.

    Article  PubMed  Google Scholar 

  38. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249–72.

    Article  CAS  PubMed  Google Scholar 

  39. Maki DG, Mermel LA. Infections due to infusion therapy. In: Bennett JV and Brachman PS, eds; Hospital infections, 2014; 38:561–91.

    Google Scholar 

  40. Pettigrew RA, Lang SD, Haydock DA, Parry BR, Bremner DA, Hill GL. Catheter-related sepsis in patients on intravenous nutrition: a prospective study of quantitative catheter cultures and guidewire changes for suspected sepsis. Br J Surg. 1985;72:52–5.

    Article  CAS  PubMed  Google Scholar 

  41. Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis. 1992;14:75–82.

    Article  CAS  PubMed  Google Scholar 

  42. Fowler Jr VG, Li J, Corey GR, Boley J, Marr KA, Gopal AK, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol. 1997;30:1072–8.

    Article  PubMed  Google Scholar 

  43. Fowler Jr VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653–65.

    Article  CAS  PubMed  Google Scholar 

  44. Grayson ML. The treatment triangle for staphylococcal infections. N Engl J Med. 2006;355:724–7.

    Article  CAS  PubMed  Google Scholar 

  45. Nucci M, Colombo AL. Risk factors for breakthrough candidemia. Eur J Clin Microbiol Infect Dis. 2002;21:209–11.

    Article  CAS  PubMed  Google Scholar 

  46. Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med. 1994;331:1325–30.

    Article  CAS  PubMed  Google Scholar 

  47. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161–89.

    Article  PubMed  Google Scholar 

  48. Gaillard JL, Merlino R, Pajot N, Goulet O, Fauchere JL, Ricour C, et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Parenter Enteral Nutr. 1990;14:593–7.

    Article  CAS  PubMed  Google Scholar 

  49. Guggenbichler JP, Berchtold D, Allerberger F, Bonatti H, Hager J, Pfaller W, et al. In vitro and in vivo effect of antibiotics on catheters colonized by staphylococci. Eur J Clin Microbiol Infect Dis. 1992;11:408–15.

    Article  CAS  PubMed  Google Scholar 

  50. Simon VC, Simon M. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters. Scand J Infect Dis Suppl. 1990;72:14–9.

    CAS  PubMed  Google Scholar 

  51. Kropec A, Huebner J, Wursthorn M, Daschner FD. In vitro activity of vancomycin and teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis colonizing catheters. Eur J Clin Microbiol Infect Dis. 1993;12:545–8.

    Article  CAS  PubMed  Google Scholar 

  52. Pascual A, Ramirez de Arellano E, Martinez Martinez L, Martínez Martínez L, Perea EJ. Effect of polyurethane catheters and bacterial biofilms on the in-vitro activity of antimicrobials against Staphylococcus epidermidis. J Hosp Infect. 1993;24: 211–8.

    Google Scholar 

  53. Ramirez de Arellano E, Pascual A, Martinez-Martinez L, Perea EJ. Activity of eight antibacterial agents on Staphylococcus epidermidis attached to Teflon catheters. J Med Microbiol. 1994; 40: 43–7.

    Google Scholar 

  54. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 1988;12:185–9.

    Article  CAS  PubMed  Google Scholar 

  55. Douard MC, Arlet G, Leverger G, Paulien R, Waintrop C, Clementi E, et al. Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med. 1991;17:30–5.

    Article  CAS  PubMed  Google Scholar 

  56. Messing B, Man F, Colimon R, Thuillier F, Beliah M. Antibiotic-lock technique is an effective treatment of bacterial catheter-related sepsis during parenteral nutrition. Clin Nutr. 1990;9:220–5.

    Article  CAS  PubMed  Google Scholar 

  57. Arnow PM, Kushner R. Malassezia furfur catheter infection cured with antibiotic lock therapy. Am J Med. 1991;90:128–30.

    Article  CAS  PubMed  Google Scholar 

  58. Cowan CE. Antibiotic lock technique. J Intraven Nurs. 1992;15:283–7.

    CAS  PubMed  Google Scholar 

  59. Elian JC, Frappaz D, Ros A, Gay JP, Guichard D, Dorche G, et al. Study of serum kinetics of vancomycin during the “antibiotic-lock” technique. Arch Fr Pediatr. 1992;49:357–60.

    CAS  PubMed  Google Scholar 

  60. Krzywda EA, Andris DA, Edmiston Jr CE, Quebbeman EJ. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol. 1995;16:596–8.

    Article  CAS  PubMed  Google Scholar 

  61. Fowler Jr VG, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Int Med. 2003;163:2066–72.

    Article  Google Scholar 

  62. Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis. 1992;11:675–82.

    Article  CAS  PubMed  Google Scholar 

  63. Verghese A, Widrich WC, Arbeit RD. Central venous septic thrombophlebitis—the role of medical therapy. Medicine. 1985;64:394–400.

    Article  CAS  PubMed  Google Scholar 

  64. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet. 2000;355:1864–8.

    Article  CAS  PubMed  Google Scholar 

  65. Fernandez-Guerrero ML, Verdejo C, Azofra J, de Górgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis. 1995;20:16–23.

    Article  CAS  PubMed  Google Scholar 

  66. Lamas CC, Eykyn SJ. Hospital acquired native valve endocarditis: analysis of 22 cases presenting over 11 years. Heart. 1998;79:442–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Terpenning MS, Buggy BP, Kauffman CA. Hospital-acquired infective endocarditis. Arch Int Med. 1988;148:1601–3.

    Article  CAS  Google Scholar 

  68. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–43.

    Article  CAS  PubMed  Google Scholar 

  69. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231–8.

    Article  CAS  PubMed  Google Scholar 

  70. Timsit JF, Sebille V, Farkas JC, Misset B, Martin JB, Chevret S, et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA. 1996;276:1416–20.

    Article  CAS  PubMed  Google Scholar 

  71. Timsit JF, Bruneel F, Cheval C, Mamzer MF, Garrouste-Orgeas M, Wolff M, et al. Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann Intern Med. 1999;130:729–35.

    Article  CAS  PubMed  Google Scholar 

  72. Johnson DW, van Eps C, Mudge DW, Wiggins KJ, Armstrong K, Hawley CM, et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol. 2005;16:1456–62.

    Article  CAS  PubMed  Google Scholar 

  73. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunneled, cuffed haemodialysis catheters. Nephrol Dial Transplant. 2002;17:1802–7.

    Article  CAS  PubMed  Google Scholar 

  74. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int. 1991;40:934–8.

    Article  CAS  PubMed  Google Scholar 

  75. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA. 1992;267:2072–6.

    Article  CAS  PubMed  Google Scholar 

  76. Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001;107:1431–6.

    Article  CAS  PubMed  Google Scholar 

  77. Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother. 2006;58:281–7.

    Article  CAS  PubMed  Google Scholar 

  78. Halpin DP, O’Byrne P, McEntee G, Hennessy TP, Stephens RB. Effect of a betadine connection shield on central venous catheter sepsis. Nutrition. 1991;7:33–4.

    CAS  PubMed  Google Scholar 

  79. Lucet JC, Hayon J, Bruneel F, Dumoulin JL, Joly-Guillou ML. Microbiological evaluation of central venous catheter administration hubs. Infect Control Hosp Epidemiol. 2000;21:40–2.

    Article  CAS  PubMed  Google Scholar 

  80. Berthelot P, Zeni F, Pain P, Berthier S, Aubert G, Venet C, et al. Catheter infection in intensive care: influence of systematic replacement of central venous catheters on a guide wire every 4 days. Presse Med. 1997;26:1089–94.

    CAS  PubMed  Google Scholar 

  81. Cobb DK, High KP, Sawyer RG, Sable CA, Adams RB, Lindley DA, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med. 1992;327:1062–8.

    Article  CAS  PubMed  Google Scholar 

  82. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med. 1990;18:1073–9.

    Article  CAS  PubMed  Google Scholar 

  83. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med. 1997;127:267–74.

    Article  CAS  PubMed  Google Scholar 

  84. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281:261–7.

    Article  CAS  PubMed  Google Scholar 

  85. Capdevila JA, Segarra A, Planes A. Long term follow-up of patients with catheter related sepsis (CRS) treated without catheter removal. 35th Interscience Conference of Antimicrobial Agents and Chemotherapy;J3:(Abstract), San Francisco, 1995.

    Google Scholar 

  86. Mermel LA, Stolz SM, Maki DG. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis. 1993;167:920–4.

    Article  CAS  PubMed  Google Scholar 

  87. Appelgren P, Ransjo U, Bindslev L, Espersen F, Larm O. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit Care Med. 1996;24:1482–9.

    Article  CAS  PubMed  Google Scholar 

  88. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med. 1988;85:307–14.

    Article  CAS  PubMed  Google Scholar 

  89. Flowers III RH, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA. 1989;261:878–83.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donald E. Craven MD, FACP, FIDSA, FRCP(C) .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Craven, D.E., Craven, K.A. (2016). Vascular Catheter-Related Bloodstream Infections. In: O'Donnell, J., Nácul, F. (eds) Surgical Intensive Care Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-19668-8_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19668-8_29

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19667-1

  • Online ISBN: 978-3-319-19668-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics